Market by Component, Deployment Mode, and Country Outlook | Forecast 2023-2030
Triton Market Research’s report estimates that the pharmaceutical supply chain management market in North America is expected to develop with a compound annual growth rate of 8.78% during the forecast years 2023-2030.
Report scope can be customized per your requirements - Request Free Sample Report
The
countries researched in the region are:
•
United States
•
Canada
The region leads in embracing modern
technologies, with the highest adoption rates. According to estimates,
smartphone usage is around 82% in the US and 86% in Canada. These widespread
internet and smartphone trends facilitate the integration of supply chain
management solutions across sectors, including healthcare. Moreover, the
continuous advancements in developing vaccines and drugs increase the demand
for these solutions. As a result, the pharmaceutical supply chain management
market is gaining the potential to leverage these technological foundations for
streamlined operations, improved distribution, and increased overall
performance.
As per estimates, the US dominates the region’s
market with the highest share.
The country stands as the global epicenter for the healthcare sector, hosting a
significant number of companies offering healthcare services and products.
Moreover, the country has the highest per capita spending on healthcare. As a
result, healthcare manufacturing firms ramp up their production of medicines
and medical devices to cater to patient needs. This, in turn, fuels the
adoption of supply chain solutions to efficiently transport medical devices,
from manufacturers to end-users.
The warehouse management system (WMS) includes
critical aspects such as inventory management, picking procedures, reporting,
and auditing. Additionally, it plays a central role in the warehouse supply
chain. It works with or is integrated with other networked systems, which
include inventory management systems, transportation management systems (TMS),
and enterprise resource planning (ERP). The functionality of WMS is gaining
importance in pharmaceutical logistics.
The
pharmaceutical supply chain management market is segmented into component and
deployment mode. The
component section is bifurcated into solution and service. The solution is
further segmented into transportation management system, planning and
analytics, manufacturing execution system, warehouse and inventory management,
and procurement and sourcing.
The
prominent companies in the pharmaceutical supply chain management market
include Infor, Cardinal Health Inc, Oracle Corporation, Tecsys Inc, SAP
SE, and Jump Technologies.
Jump Technologies Inc offers
software-as-a-service (SaaS) based inventory management solutions that enhance
inventory outcomes and cash flow while optimizing staff efficiency. Moreover,
the software offers clear supply visibility, from the loading dock to patient
care. Jump Technologies serves clients globally, with headquarters in
Minnesota, United States.
Key
deliverables of the report:
●
Market CAGR during the forecasting years 2023-2030
●
Detailed data highlighting key insights, industry components, and
market strategies
●
Comprehensive information and estimation of the pharmaceutical
supply chain management market revenue growth in North America and its
influence on the parent market
●
In-depth study of forthcoming trends in consumer behavioral
patterns
●
A meticulous analysis of the competitive landscape, vendor
scorecard, and Porter’s Five Forces
●
A wide-ranging study of factors that will challenge the NA
pharmaceutical supply chain management market’s growth during the upcoming
years
Want to get specific insights? Our team of analysts
can customize this report based on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. NORTH
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET
2.1.1. COVID-19
IMPACT
2.2. KEY
INSIGHT
2.2.1. EMBRACING
MODERN INVENTORY SOLUTIONS FOR DECENTRALIZED SUPPLY CHAIN
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE S
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. REGULATORY
FRAMEWORK
2.5. KEY
BUYING IMPACT ANALYSIS
2.5.1. COMPETITIVE
PRICING
2.5.2. INTEGRATION
CAPABILITIES
2.5.3. INVENTORY
MANAGEMENT
2.5.4. ANALYTICS
AND BUSINESS INTELLIGENCE
2.5.5. SECURITY
AND DATA PRIVACY
2.6. KEY
MARKET STRATEGIES
2.6.1. COLLABORATIONS
2.6.2. PRODUCT
LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISING
ADOPTION OF CLOUD COMPUTING SYSTEMS IN HEALTHCARE
2.7.2. IMPLEMENTATION
OF GS1 STANDARD
2.7.3. GROWING
EMPHASIS ON REDUCING HEALTHCARE EXPENDITURE
2.7.4. INCREASING
DEMAND FOR PHARMACEUTICAL PRODUCTS
2.7.5. CONCERN
REGARDING DRUG COUNTERFEITING
2.8. MARKET
CHALLENGES
2.8.1. REGULATORY
CHALLENGES IN HEALTHCARE DATA EXCHANGE
2.8.2. HIGH
COST OF SUPPLY CHAIN MANAGEMENT SOFTWARE
2.8.3. SCM
SOFTWARE ENCOUNTERS TECHNICAL ISSUES
2.8.4. PRIVACY
CONCERNS ARISING IN SCM LINKS
2.9. MARKET
OPPORTUNITIES
2.9.1. ADVANCEMENTS
IN CLINICALLY INTEGRATED SUPPLY CHAINS
2.9.2. ENHANCING
QUALITY AND CARE WITH ADVANCED SUPPLY CHAIN TECHNOLOGIES
3. NORTH
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COMPONENT
3.1. SOLUTION
3.1.1. TRANSPORTATION
MANAGEMENT SYSTEM
3.1.2. PLANNING
AND ANALYTICS
3.1.3. WAREHOUSE
AND INVENTORY MANAGEMENT SYSTEM
3.1.4. PROCUREMENT
AND SOURCING
3.1.5. MANUFACTURING
EXECUTION SYSTEM
3.2. SERVICE
3.2.1. PROFESSIONAL
SERVICES
3.2.2. MANAGED
SERVICES
4. NORTH
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY DEPLOYMENT MODE
4.1. ON-PREMISE
4.2. CLOUD-BASED
5. NORTH
AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET – BY COUNTRY OUTLOOK
5.1. COUNTRY
ANALYSIS
5.1.1. UNITED
STATES
5.1.1.1. UNITED
STATES PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
5.1.2. CANADA
5.1.2.1. CANADA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET FORECAST & PROSPECTS
6. COMPETITIVE
LANDSCAPE
6.1. MCKESSON
CORPORATION
6.1.1. OVERVIEW
6.1.2. PRODUCT
PORTFOLIO
6.1.3. KEY
STRENGTHS
6.1.4. KEY
CHALLENGES
6.2. INFOR
6.2.1. OVERVIEW
6.2.2. PRODUCT
PORTFOLIO
6.2.3. KEY
STRENGTHS
6.2.4. KEY
CHALLENGES
6.3. ORACLE
CORPORATION
6.3.1. OVERVIEW
6.3.2. PRODUCT
PORTFOLIO
6.3.3. KEY
STRENGTHS
6.3.4. KEY
CHALLENGES
6.4. CARDINAL
HEALTH INC
6.4.1. OVERVIEW
6.4.2. PRODUCT
PORTFOLIO
6.4.3. KEY
STRENGTHS
6.4.4. KEY
CHALLENGES
6.5. TECSYS
INC
6.5.1. OVERVIEW
6.5.2. PRODUCT
PORTFOLIO
6.5.3. KEY
STRENGTHS
6.5.4. KEY
CHALLENGES
6.6. SAP SE
6.6.1. OVERVIEW
6.6.2. PRODUCT
PORTFOLIO
6.6.3. KEY
STRENGTHS
6.6.4. KEY
CHALLENGES
6.7. JUMP
TECHNOLOGIES INC
6.7.1. OVERVIEW
6.7.2. PRODUCT
PORTFOLIO
6.8. MANHATTAN
ASSOCIATES INC
6.8.1. OVERVIEW
6.8.2. PRODUCT
PORTFOLIO
6.8.3. KEY
STRENGTHS
6.8.4. KEY
CHALLENGES
6.9. TERSO
SOLUTIONS INC
6.9.1. OVERVIEW
6.9.2. PRODUCT
PORTFOLIO
6.9.3. KEY
STRENGTHS
6.9.4. KEY
CHALLENGES
6.10. ARVATO
GROUP
6.10.1. OVERVIEW
6.10.2. PRODUCT
PORTFOLIO
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
7.3.1. DATA
VALIDATION & ANALYSIS
TABLE 1: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2023-2030
(IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK
TABLE 3: LIST OF
COLLABORATIONS
TABLE 4: LIST OF PRODUCT
LAUNCHES
TABLE 5: MAJOR FACTORS
CONTRIBUTING TO THE WIDESPREAD PRESENCE OF COUNTERFEIT GOODS
TABLE 6: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2023-2030 (IN $
MILLION)
TABLE 7: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2023-2030 (IN $
MILLION)
TABLE 8: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2023-2030 (IN $
MILLION)
TABLE 9: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2023-2030
(IN $ MILLION)
TABLE
10: NORTH AMERICA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY
OUTLOOK, 2023-2030 (IN $ MILLION)
FIGURE 1: KEY BUYING IMPACT
ANALYSIS
FIGURE 2: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COMPONENT, 2022 & 2030
(IN %)
FIGURE 3: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SOLUTION, 2022 & 2030 (IN
%)
FIGURE 4: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY TRANSPORTATION MANAGEMENT
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 5: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PLANNING AND ANALYTICS,
2023-2030 (IN $ MILLION)
FIGURE 6: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY WAREHOUSE AND INVENTORY
MANAGEMENT SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 7: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROCUREMENT AND SOURCING, 2023-2030
(IN $ MILLION)
FIGURE 8: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANUFACTURING EXECUTION
SYSTEM, 2023-2030 (IN $ MILLION)
FIGURE 9: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY SERVICE, 2022 & 2030 (IN
%)
FIGURE 10: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY PROFESSIONAL SERVICES,
2023-2030 (IN $ MILLION)
FIGURE 11: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY MANAGED SERVICES, 2023-2030
(IN $ MILLION)
FIGURE 12: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY DEPLOYMENT MODE, 2022 &
2030 (IN %)
FIGURE 13: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY ON-PREMISE, 2023-2030 (IN $
MILLION)
FIGURE 14: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY CLOUD-BASED, 2023-2030 (IN $
MILLION)
FIGURE 15: NORTH AMERICA
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET, BY COUNTRY OUTLOOK, 2022 &
2030 (IN %)
FIGURE 16: UNITED STATES
PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $ MILLION)
FIGURE
17: CANADA PHARMACEUTICAL SUPPLY CHAIN MANAGEMENT MARKET 2023-2030 (IN $
MILLION)